4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing

Core Viewpoint - Lucid Diagnostics has reached a significant milestone with the 4,000th firefighter undergoing esophageal precancer testing using its EsoGuard® Esophageal DNA test, highlighting the proactive measures taken by the firefighter community to combat the elevated cancer risks they face [1][6]. Company Overview - Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company and a subsidiary of PAVmed Inc., focusing on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer [3][8]. - The EsoGuard® Esophageal DNA Test is designed for early detection of esophageal precancer through a noninvasive procedure using the EsoCheck® Esophageal Cell Collection Device, which is the first and only commercially available tool aimed at preventing cancer through early detection [3][6]. Event Details - The CheckYourFoodTube event, organized in partnership with Mass General Brigham and Boston Firefighters Local 718 IAFF, is part of a series of initiatives aimed at screening firefighters for esophageal precancer [1][2]. - This event marks the 105th occurrence of the CheckYourFoodTube initiative, which is integral to Lucid's strategy to increase test volume and awareness among at-risk populations [2][6]. Industry Context - Firefighters face a 62% increased risk of developing esophageal cancer and a 39% increased risk of dying from it, according to the Firefighter Cancer Support Group [6]. - The American Cancer Society estimates that in 2024, there will be 22,370 new cases of esophageal cancer, with 16,130 deaths attributed to the disease [6].